Protocol for intraventricular injection of retinoids and hypothalamic application of viral vectors in the rat and mouse brain

Read full text
Authors: Peter I. Imoesi, Cristian M. Olarte-Sánchez, Lora Heisler, Peter McCaffery
Cited by: 2
References: 3

Abstract

The brain, specifically the hypothalamus, is a key regulator of the homeostatic balance of numerous biomolecules in the body via its control of the neuroendocrine system. Here, we present a protocol to study body vitamin A balance by injecting synthetic retinoids into the third ventricle of the rat brain. We also describe steps for the intraventricular application of viral vectors to the arcuate nucleus of a mouse brain to knock down vitamin A homeostatic genes. This approach is applicable to the study of vitamin A homeostasis. For complete details on the use and execution of this protocol, please refer to Imoesi et al. 1 • Protocol to study vitamin A homeostasis in the rodent body • Steps for injecting synthetic retinoids into the third ventricle of the rat brain • Procedures for the intraventricular application of viral vectors Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics. The brain, specifically the hypothalamus, is a key regulator of the homeostatic balance of numerous biomolecules in the body via its control of the neuroendocrine system. Here, we present a protocol to study body vitamin A balance by injecting synthetic retinoids into the third ventricle of the rat brain. We also describe steps for the intraventricular application of viral vectors to the arcuate nucleus of a mouse brain to knock down vitamin A homeostatic genes. This approach is applicable to the study of vitamin A homeostasis.

Fields of Study & Subjects

Retinoids in leukemia and cellular processes Antioxidant Activity and Oxidative Stress Retinal Development and Disorders

Publication details

Journal / source
STAR Protocols
Publisher
Elsevier BV
Volume
7
Issue
1
Pages
104329–104329
Publication date
31 January 2026
Language
EN